Skip to content
Part 2 of our Year in Review video series is out now.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Read more about the article Pα+: MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics

Pα+: MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics

  • Post published:November 8, 2023
  • Post category:Analysis/News/Pα+
Read more about the article MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics

MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics

  • Post published:November 8, 2023
  • Post category:Analysis/News
Read more about the article The Psychedelic News Feed: Oct 9 – Nov 5, 2023

The Psychedelic News Feed: Oct 9 – Nov 5, 2023

  • Post published:November 6, 2023
  • Post category:Psychedelic News Feed Archive
Read more about the article Psychedelic Bulletin #148 (Pα+)

Psychedelic Bulletin #148 (Pα+)

  • Post published:November 3, 2023
  • Post category:Psychedelic Bulletin/Pα+
Read more about the article Introducing Pα+

Introducing Pα+

  • Post published:November 1, 2023
  • Post category:Announcements
Read more about the article Cybin Shares Positive Interim Topline Data for Deuterated Psilocybin Analog Candidate

Cybin Shares Positive Interim Topline Data for Deuterated Psilocybin Analog Candidate

  • Post published:October 31, 2023
  • Post category:Analysis/News
Read more about the article Colorado DOR Natural Medicine Division Listening Sessions: Part 1

Colorado DOR Natural Medicine Division Listening Sessions: Part 1

  • Post published:October 24, 2023
  • Post category:Colorado Natural Medicine Advisory Bulletin
Read more about the article Psychedelic Bulletin #147: Newsom Vetoes Psychedelic Decrim. in CA; At-Home Ketamine Gets a Lifeline and a Warning; Drug Development Updates from GH, atai, Cybin; and more

Psychedelic Bulletin #147: Newsom Vetoes Psychedelic Decrim. in CA; At-Home Ketamine Gets a Lifeline and a Warning; Drug Development Updates from GH, atai, Cybin; and more

  • Post published:October 17, 2023
  • Post category:Psychedelic Bulletin
Read more about the article Natural Medicine Advisory Bulletin #4: September 2023

Natural Medicine Advisory Bulletin #4: September 2023

  • Post published:October 11, 2023
  • Post category:Colorado Natural Medicine Advisory Bulletin
Read more about the article Introducing the Psychedelic News Feed

Introducing the Psychedelic News Feed

  • Post published:October 10, 2023
  • Post category:News

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More